Answer
The most frequently reported adverse reactions to bimekizumab are upper respiratory tract infections and oral candidiasis.
Sources for this answer
- Bimzelx 160 mg solution for injection in pre-filled penUCB Pharma Limited · emc · SmPC §4.8 Undesirable effects · Version 11Document updated
Sources checked